Conversion of 7-Carboxy-Cannabidiol (7-COOH-CBD) to 11-nor-9-Carboxy-Tetrahydrocannabinol (THC-COOH) During Sample Preparation for GC-MS Analysis
The growing use of cannabidiol (CBD) products by the general public is expected to result in an increase in the prevalence of CBD and the CBD metabolites in drug testing laboratories. CBD converts into tetrahydrocannabinol (THC) under acid conditions which could produce false positive results but little is known about how the presence of the urinary metabolite of CBD, 7-carboxy-cannabidiol (7-COOH-CBD) would affect urine drug testing for 11-nor-9-carboxy-tetrahydrocannabinol (THC-COOH). As the operators of the National Laboratory Certification Program (NLCP) we prepared a set of performance testing (PT) samples containing 7-COOH-CBD for cannabinoids testing at the laboratories accredited by the NLCP to investigate if 7-COOH-CBD can produce false positive results for THC-COOH during immunological screening analysis and if 7-COOH-CBD can be converted to THC-COOH. At concentrations up to 2,500 ng/mL, 7-COOH-CBD was not reactive by immunoassay in any of the four different immunoassay kits used. Additionally, we did not observe any significant conversion of 7-COOH-CBD to THC-COOH in assays used by NLCP certified laboratories. However, we did see conversion when we requested that selected laboratories retest their samples using derivatization with perfluorinated anhydrides in combination with perfluorinated alcohols or when samples containing 7-COOH-CBD were exposed to acid for an extended time.
Keywords: GC-MS; cannabidiol; derivatization; immunoassay; tetrahydrocannabinol; urine.
© The Author(s) 2021. Published by Oxford University Press on behalf of Society of Forensic Toxicologists, Inc. All rights reserved. For permissions, please e-mail: email@example.com.
Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.
J Anal Toxicol. 2017 May 1;41(4):277-288. doi: 10.1093/jat/bkw136. J Anal Toxicol. 2017. PMID: 28069869 Free PMC article.
Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
J Anal Toxicol. 2005 Nov-Dec;29(8):782-9. doi: 10.1093/jat/29.8.782. J Anal Toxicol. 2005. PMID: 16356335 Clinical Trial.
Hair analysis for delta(9)-THC, delta(9)-THC-COOH, CBN and CBD, by GC/MS-EI. Comparison with GC/MS-NCI for delta(9)-THC-COOH.
Forensic Sci Int. 2002 Aug 14;128(1-2):66-78. doi: 10.1016/s0379-0738(02)00154-8. Forensic Sci Int. 2002. PMID: 12208025
A critical review on the detection, occurrence, fate, toxicity, and removal of cannabinoids in the water system and the environment.
Environ Pollut. 2021 Jan 1;268(Pt A):115642. doi: 10.1016/j.envpol.2020.115642. Epub 2020 Sep 14. Environ Pollut. 2021. PMID: 33032096 Free PMC article. Review.
Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature.
Toxics. 2020 Jun 3;8(2):41. doi: 10.3390/toxics8020041. Toxics. 2020. PMID: 32503116 Free PMC article. Review.
L’article Conversion of 7-Carboxy-Cannabidiol (7-COOH-CBD) to 11-nor-9-Carboxy-Tetrahydrocannabinol (THC-COOH) During Sample Preparation for GC-MS Analysis est apparu en premier sur Cannabis Belgique.